A carregar...
The frequency and availability of population-specific patient reported outcome measures and minimal clinically important differences among approved drugs in Canada
BACKGROUND: Patient reported outcome measures (PROMs) and minimal clinically important differences (MCIDs) are included in Canada’s Common Drug Review (CDR) process to approve new drugs. Often, the measures report on the health-related quality of life (HRQoL), but can also describe the symptoms, eff...
Na minha lista:
| Publicado no: | Health Qual Life Outcomes |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6322322/ https://ncbi.nlm.nih.gov/pubmed/30616654 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12955-018-1070-0 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|